All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY823 | Anti-KDM6A (1612) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1612 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY824 | Anti-KDM6A (5C2A9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 5C2A9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY825 | Anti-KDM6A (6E2D6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human, Rat | 6E2D6 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY826 | Anti-KDM6A (GT1612) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | GT1612 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY958 | Anti-KDM6A (3A2) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Human | 3A2 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY959 | Anti-KDM6A (4E7) h(41BB-CD3ζ) CAR, pCDCAR1 | 4E7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY2463 | Anti-KDM6A(1612) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1612 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2464 | Anti-KDM6A(5C2A9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 5C2A9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2465 | Anti-KDM6A(6E2D6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human, Rat | 6E2D6 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2466 | Anti-KDM6A(GT1612) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | GT1612 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2598 | Anti-KDM6A(3A2) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Human | 3A2 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2599 | Anti-KDM6A(4E7) h(CD28-CD3ζ) CAR, pCDCAR1 | 4E7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION